Skip to main content
Clinical Trials/NCT01184430
NCT01184430UnknownNot Applicable

Monocentric Pilot Study of Effect of Perioperative Hemodynamic Optimization on the Immune Function Parameters of Peripheral Blood Monocytes After Cardiac Surgery

Charite University, Berlin, Germany1 site in 1 country40 target enrollmentStarted: August 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
40
Locations
1
Primary Endpoint
HLA-DR Expression on monocytes after surgery

Study Overview

Brief Summary

Cardiac surgery patients have a high risk to suffer from postoperative infections. Some studies have shown, that humoral and cellular factors are associated with perioperative immunodysfunction and can increase the risk of postoperative infections. Monocytes in the blood and, especially alveolar macrophages are important for an adequate host defence. In studies the investigators have shown that hemodynamic parameters have a significant influence on the probability to develop postoperative infections. The aim of the study is to investigate, whether cardiac surgery patients have an altered immune function after surgery that is predictive for the latter development of subsequent infections and whether they benefit from a goal-directed volume and hemodynamic therapy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •elective cardiac surgery patient undergoing cardiopulmonary bypass
  • •signed informed consent

Exclusion Criteria

  • •pregnant or breast feeding women
  • •Age <18 years
  • •pulmonary disease with an oxygenation index <300mmHg
  • •liver disease (>Child B)
  • •HIV-Infection
  • •Therapy with corticosteroids
  • •Condition after transplantation
  • •preexisting infection before operation

Arms & Interventions

advanced hemodynamic monitoring

Active Comparator

advanced hemodynamic monitoring with pulse contour analysis ( LiDCO rapid) and goal-directed therapy

Intervention: Pulse contour cardiac output device (Device)

standard monitoring

No Intervention

hemodynamic monitoring based on the standard operating procedures of our clinic

Outcomes

Primary Outcomes

HLA-DR Expression on monocytes after surgery

Time Frame: 24 hours

Secondary Outcomes

  • ICU stay(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Sander

Vice Chair

Charite University, Berlin, Germany

Study Sites (1)

Loading locations...

Similar Trials